GFFFX | LGLAX | GFFFX / LGLAX | |
Total Expense Ratio | 0.40 | 0.90 | 44% |
Annual Report Gross Expense Ratio | 0.40 | 0.90 | 44% |
Fund Existence | 17 years | 14 years | - |
Gain YTD | 14.426 | 15.707 | 92% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 250 | 1500 | 17% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 329B | 7.9B | 4,167% |
Annual Yield % from dividends | 0.52 | 0.00 | - |
Returns for 1 year | 14.95 | 36.62 | 41% |
Returns for 3 years | 43.37 | 75.02 | 58% |
Returns for 5 years | 45.50 | 38.66 | 118% |
Returns for 10 years | 88.99 | 127.47 | 70% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSMEX | 59.74 | 0.38 | +0.64% |
Fidelity Select Medical Tech and Devcs | |||
GRSPX | 26.41 | -0.01 | -0.04% |
Cromwell Greenspring Mid Cap Instl | |||
BRWVX | 28.10 | -0.06 | -0.21% |
MFS Blended Research Growth Eq R6 | |||
VSCIX | 117.86 | -0.44 | -0.37% |
Vanguard Small Cap Index I | |||
PMFMX | 23.13 | -0.14 | -0.60% |
Principal MidCap S&P 400 Index R3 |